Stem Cell Veto Could Hurt U.S. Competitiveness, Says William Caldwell, CEO of Advanced Cell Technology
June 22, 2007
Caldwell's company is working on stem-cell-based therapies for macular degeneration. Bloomberg TV interviewed him this week for his views. Watch here.
Latest from Home
Latest from Home